Literature DB >> 15608474

Effect of self-medication with antimalarial drugs on malaria infection in pregnant women in South-Western Nigeria.

O M Akanbi1, A B Odaibo, K A Afolabi, O G Ademowo.   

Abstract

OBJECTIVE: To determine the effect of self-medication with chloroquine and pyrimethamine on malaria infection and anaemia during pregnancy. SUBJECTS AND METHODS: The study involved 210 women who attended Ade Oyo Maternity State Hospital, Ibadan, Nigeria. Of these, 156 were pregnant women while 54 were not pregnant (controls). Of the pregnant women, 66 were primigravidae, while 90 were multigravidae. History of treatment of malaria with antimalarial drugs was obtained from the subjects. Gravidity and gestation period were also documented. Two millilitres of blood was withdrawn from each subject, for haematological parameters. Thin and thick films were prepared for malaria parasite identification and quantification.
RESULTS: Of the primigravidae and multigravidae 68 and 16.4%, respectively, had taken antimalarial drugs prior to booking. Among primigravidae, only 18% of those with drugs compared with 32% without drugs were malaria-positive. The parasite density was significantly lower among those who took antimalarial drugs than among those who did not (976 +/- 60 versus 2,421 +/- 78, p < 0.05). Similarly, among multigravidae, only 16.4% of those who took antimalarial drugs compared with 34% of those who were not malaria-positive. The parasite density was also significantly lower in multigravidae with drugs than among those without drugs (350 +/- 45 versus 1,000 +/- 65, p < 0.05). The prevalence of anaemia (packed cell volume, PCV < 33) was high, 89% in primigravidae and 70% in multigravidae. Severe anaemia (PCV < 21) was more common in malaria-positive primigravidae and multigravidae than in malaria-negative women.
CONCLUSION: The findings indicate that self-medication with chloroquine and pyrimethamine at booking was able to reduce the prevalence of malaria and anaemia in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608474     DOI: 10.1159/000081915

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  7 in total

1.  Determinants of self medication practices among pregnant women in Ibadan, Nigeria.

Authors:  Kazeem B Yusuff; Louis-Domeih Omarusehe
Journal:  Int J Clin Pharm       Date:  2011-09-01

2.  Patterns and predictors of self-medication amongst antenatal clients in Ibadan, Nigeria.

Authors:  Folasade A Bello; Imran O Morhason-Bello; Oladapo Olayemi; Adeyemi O Adekunle
Journal:  Niger Med J       Date:  2011-07

3.  Pattern, awareness and perceptions of health hazards associated with self medication among adult residents of kano metropolis, northwestern Nigeria.

Authors:  Umar M Lawan; Isa S Abubakar; Abubakar M Jibo; Ahmed Rufai
Journal:  Indian J Community Med       Date:  2013-07

4.  Prevalence and Reasons of Self-Medication in Pregnant Women: A Systematic Review and Meta-Analysis.

Authors:  Mohammad Mohseni; Saber Azami-Aghdash; Sepideh Gareh Sheyklo; Ahmad Moosavi; Majid Nakhaee; Fatemeh Pournaghi-Azar; Aziz Rezapour
Journal:  Int J Community Based Nurs Midwifery       Date:  2018-10

5.  Long-term administration of artesunate induces reproductive toxicity in male rats.

Authors:  Stephen Akinsomisoye Olumide; Yinusa Raji
Journal:  J Reprod Infertil       Date:  2011-10

6.  Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.

Authors:  Catherine O Falade; Bidemi O Yusuf; Francis F Fadero; Olugbenga A Mokuolu; Davidson H Hamer; Lateef A Salako
Journal:  Malar J       Date:  2007-07-06       Impact factor: 2.979

7.  Evaluation of the performances of two rapid diagnostic tests (Cyscope®mini and Paracheck-Pf®) in the diagnosis of malaria among febrile children in southwest Nigeria.

Authors:  Olawunmi R Rabiu; Ayokulehin M Kosoko; Catherine O Falade; Olusegun G Ademowo
Journal:  Med Princ Pract       Date:  2012-12-21       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.